BiotechTube
Home/Medicure/Albert D. Friesen
AD

Albert D. Friesen

Chief Executive Officer & Chairman of the Board

Medicure

Therapeutic Areas

CardiovascularRare Pediatric NeurologyNeurology

Medicure Pipeline

DrugIndicationPhase
MC-1 (Pyridoxal 5'-Phosphate)Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) DeficiencyPhase 3
Unspecified ProgramTardive DyskinesiaResearch